Expressions of glucose transporter Types 1 and 3 and hexokinase-II in diffuse large B-cell lymphoma and other B-cell non-Hodgkin's lymphomas

This publication has 21 references indexed in Scilit:

• High correlations between primary tumours and loco-regional metastatic lymph nodes in non-small-cell lung cancer with respect to glucose transporter type 1-mediated 2-deoxy-2-F18-fluoro-d-glucose uptake
  European Journal of Cancer, 2008
• Expression of glucose transporters and hexokinase II in cholangiocellular carcinoma compared using [¹⁸F]‐2‐fluro‐2‐deoxy‐d‐glucose positron emission tomography
  Cancer Science, 2008
• Warburg, me and Hexokinase 2: Multiple discoveries of key molecular events underlying one of cancers’ most common phenotypes, the “Warburg Effect”, i.e., elevated glycolysis in the presence of oxygen
  Journal of Bioenergetics and Biomembranes, 2007
• The usefulness of ¹⁸F‐fluorodeoxyglucose positron emission tomography (¹⁸F‐FDG‐PET) and a comparison of ¹⁸F‐FDG‐pet with ⁶⁷gallium scintigraphy in the evaluation of lymphoma
  Cancer, 2007
• Intensity of¹⁸Fluorodeoxyglucose Uptake in Positron Emission Tomography Distinguishes Between Indolent and Aggressive Non-Hodgkin’s Lymphoma
  Journal of Clinical Oncology, 2005
• Utility of Fine-Needle Aspiration As a Diagnostic Technique in Lymphoma
  Journal of Clinical Oncology, 2004
• Positron emission tomography in the evaluation of lymphoma
  Seminars in Nuclear Medicine, 2004
• PET Scans in the Staging of Lymphoma: Current Status
  The Oncologist, 2003
• Utility of FDG-PET scanning in lymphoma by WHO classification
  Blood, 2003
• The rate-limiting step for tumor [18F]fluoro-2-deoxy-D-glucose (FDG) incorporation
  Nuclear Medicine and Biology, 2001